Dramina tab. 50mg # 10

Release form, composition and packaging

?

The tablets are white, round, flat, chamfered and scored on one side.

1 tab.

Dimenhydrinate 50 mg

lactose monohydrate, microcrystalline cellulose, magnesium stearate, povidone, crospovidone.

5 pieces.

- blisters (1) - cardboard packs.

10 pieces.

- blisters (1) - cardboard packs.

pharmachologic effect

A blocker of histamine H1 receptors with anticholinergic properties.

Reduces or eliminates histamine-induced increase in the tone of smooth muscles of the bronchi, intestines, uterus, increased capillary permeability with the development of edema, hyperemia and itching.

Dimenhydrinate has a pronounced sedative and antiemetic effect. ''

Indications for use

Prevention and symptomatic treatment of nausea, vomiting and dizziness of various origins (including with Meniere's disease, kinetosis).

Contraindications for use

Hypersensitivity to dimensionhydrinate, children under 1 year of age.

Dosage regimen

In adults, it is used at a dose of 50-100 mg 4-6 times / day.

The maximum daily dose is 400 mg.

In children aged 1-6 years, it is used at a dose of 12.5-25 mg 2-3 times / day, 7-12 years old - 25-50 mg 2-3 times / day.

Side effect

Possibly: dry mouth, poor accommodation, drowsiness.

Drug interactions

When used simultaneously with sedatives, hypnotics, antidepressants, ethanol, the depressing effect on the central nervous system is enhanced.

With the simultaneous use of dimensionhydrinate can mask the ototoxicity of streptomycin and, apparently, other antibiotics of the aminoglycoside group.

Application during pregnancy and lactation

During pregnancy and lactation (breastfeeding), dimensionhydrinate is used with caution, only in cases where the expected therapeutic effect for the mother outweighs the potential risk of side effects in the fetus or child. In experimental studies, it was found that dimensionhydrinate causes the development of cardiovascular defects and inguinal hernia in the fetus.

Special instructions Dimenhydrinate is used with caution in angle-closure glaucoma, urination disorders, benign prostatic hyperplasia, epilepsy, in patients with severe cardiovascular diseases.

During the period of treatment, alcohol should be avoided.

Influence on the ability to drive vehicles and control mechanisms Patients taking dimensionhydrinate should avoid engaging in potentially hazardous activities that require increased attention and speed of psychomotor reactions.

Name ENG

DRAMINA

Clinical and pharmacological group

The drug used for kinetosis

ATX code

Other antihistamines for systemic use

Dosage

50mg

Structure

1 tablet contains: active substance - dimensionhydrinate 50 mg

Excipients: lactose monohydrate - 112.86 mg

microcrystalline cellulose - 57.50 mg, magnesium stearate - 1,150 mg

povidone K30 - 4.247 mg

crospovidone - 4,247 mg.?

Indications

motion sickness (sea, car and air sickness)

prevention and treatment of symptoms of vestibular and labyrinthine disorders (dizziness, nausea, vomiting), with the exception of symptoms caused by anticancer therapy

Meniere's disease.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 5 years

INN / Active ingredient

Dimenhydrinate

Specifications

Category

Vomiting, nausea

Scope of the drug

Gastrointestinal tract

Release form

Tablet

Manufacturer country

Croatia

Package quantity, pcs

ten

Scope of application

Gastroenterology

Minimum age from

3 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Jadran

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

H1-histamine receptor blocker

Anatomical and therapeutic characteristics

R06AX Other antihistamines for systemic use

Dosage form

Pills

Expiration date in days

1825

Dosage (volume) of the substance in the preparation

Dimenhydrinate 50 mg

The target audience

Children

Package weight, g

twenty

Mode of application

:

Inside, before eating: < br> - motion sickness (motion sickness, car sickness, air sickness): < br> children from 3 to 6 years old - 1/4 -1/2 tablets 2-3 times a day children from 7 to 12 years old - 1/2 - 1 tablet 2-3 times a day children over 12 years old and adults - 1-2 tablets 2-3 times a day < br> - prevention and treatment of symptoms of vestibular and labyrinth disorders (dizziness, nausea, vomiting), with the exception of symptoms caused by anticancer therapy: < br> children from 3 to 6 years old - 1/4 - 1/2 tablets 2-3 times a day children from 7 to 12 years old - 1 / 2-1 tablet 2-3 times a day children over 12 years old and adults - 1-2 tablets 2-3 times a day < br> - Meniere's disease: < br> children from 3 to 12 years old - 1 / 2-1 tablet 2-3 times a day children over 12 years old and adults 1-2 tablets 2-3 times a day. < br> The maximum daily dose for adults should not exceed 7 tablets. For the prevention of kinetosis, take 1-2 tablets 30 minutes before the trip. The duration of the drug use and the possibility of repeating the course of treatment - in agreement with the doctor.

Information on technical characteristics, delivery set, country of manufacture